nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—glaucoma	0.434	1	CbGaD
Phenylbutazone—SLC22A6—Methazolamide—glaucoma	0.0949	0.201	CbGbCtD
Phenylbutazone—SLC22A6—Acetazolamide—glaucoma	0.0759	0.16	CbGbCtD
Phenylbutazone—CYP2C9—Diclofenamide—glaucoma	0.0506	0.107	CbGbCtD
Phenylbutazone—CYP2C9—Dorzolamide—glaucoma	0.0489	0.103	CbGbCtD
Phenylbutazone—CYP2C9—Methazolamide—glaucoma	0.0436	0.0921	CbGbCtD
Phenylbutazone—CYP3A4—Pilocarpine—glaucoma	0.0375	0.0793	CbGbCtD
Phenylbutazone—CYP3A4—Brinzolamide—glaucoma	0.0294	0.0622	CbGbCtD
Phenylbutazone—CYP3A4—Dorzolamide—glaucoma	0.0284	0.0601	CbGbCtD
Phenylbutazone—CYP3A4—Methazolamide—glaucoma	0.0253	0.0535	CbGbCtD
Phenylbutazone—CYP3A4—Acetazolamide—glaucoma	0.0203	0.0428	CbGbCtD
Phenylbutazone—CYP3A4—Clonidine—glaucoma	0.0183	0.0387	CbGbCtD
Phenylbutazone—PTGIS—endothelium—glaucoma	0.00373	0.34	CbGeAlD
Phenylbutazone—SLC22A8—optic choroid—glaucoma	0.00287	0.262	CbGeAlD
Phenylbutazone—Clobazam—SLC6A1—glaucoma	0.00245	0.838	CrCbGaD
Phenylbutazone—PTGIS—connective tissue—glaucoma	0.00176	0.161	CbGeAlD
Phenylbutazone—PTGIS—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00117	0.0149	CbGpPWpGaD
Phenylbutazone—PTGIS—Eicosanoid Synthesis—PTGS2—glaucoma	0.0011	0.014	CbGpPWpGaD
Phenylbutazone—PTGIS—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000951	0.0121	CbGpPWpGaD
Phenylbutazone—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00095	0.0121	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000939	0.0119	CbGpPWpGaD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.00092	0.0117	CbGpPWpGaD
Phenylbutazone—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000864	0.011	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000716	0.0091	CbGpPWpGaD
Phenylbutazone—PTGS1—endothelium—glaucoma	0.000699	0.0638	CbGeAlD
Phenylbutazone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000687	0.00873	CbGpPWpGaD
Phenylbutazone—PTGS2—endothelium—glaucoma	0.000668	0.061	CbGeAlD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00064	0.00812	CbGpPWpGaD
Phenylbutazone—PTGIS—Biological oxidations—GSTT1—glaucoma	0.000634	0.00805	CbGpPWpGaD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000615	0.00782	CbGpPWpGaD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—PTGS2—glaucoma	0.000612	0.00777	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000598	0.00759	CbGpPWpGaD
Phenylbutazone—SLC22A8—eye—glaucoma	0.000578	0.0528	CbGeAlD
Phenylbutazone—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00057	0.00724	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—FN1—glaucoma	0.000561	0.00713	CbGpPWpGaD
Phenylbutazone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	0.00056	0.00711	CbGpPWpGaD
Phenylbutazone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000557	0.00708	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CA1—glaucoma	0.000549	0.00698	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000524	0.00666	CbGpPWpGaD
Phenylbutazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—glaucoma	0.00052	0.00661	CbGpPWpGaD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000508	0.00645	CbGpPWpGaD
Phenylbutazone—PTGIS—Biological oxidations—CYP1B1—glaucoma	0.000505	0.00641	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000496	0.00629	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000488	0.0062	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—PEX19—glaucoma	0.000481	0.00611	CbGpPWpGaD
Phenylbutazone—Oxaprozin—PTGS2—glaucoma	0.000473	0.162	CrCbGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000472	0.00599	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—NR3C1—glaucoma	0.000467	0.00594	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—FAS—glaucoma	0.000453	0.00575	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—FN1—glaucoma	0.000445	0.00566	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CA5A—glaucoma	0.000444	0.00564	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—NARFL—glaucoma	0.000444	0.00564	CbGpPWpGaD
Phenylbutazone—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000439	0.00557	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000438	0.00556	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—TXN—glaucoma	0.000429	0.00546	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000427	0.00542	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000417	0.0053	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—PTGS2—glaucoma	0.000408	0.00518	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000407	0.00517	CbGpPWpGaD
Phenylbutazone—PTGIS—Biological oxidations—GSTM1—glaucoma	0.000404	0.00513	CbGpPWpGaD
Phenylbutazone—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000403	0.00512	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—LRP12—glaucoma	0.000402	0.00511	CbGpPWpGaD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	0.000393	0.00499	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—PEX19—glaucoma	0.000367	0.00466	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000354	0.0045	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.000341	0.00433	CbGpPWpGaD
Phenylbutazone—PTGS1—Eicosanoid Synthesis—PTGS2—glaucoma	0.000338	0.00429	CbGpPWpGaD
Phenylbutazone—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000331	0.00421	CbGpPWpGaD
Phenylbutazone—PTGS1—connective tissue—glaucoma	0.000331	0.0302	CbGeAlD
Phenylbutazone—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000327	0.00416	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000325	0.00413	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000325	0.00413	CbGpPWpGaD
Phenylbutazone—PTGS2—connective tissue—glaucoma	0.000316	0.0288	CbGeAlD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000312	0.00397	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—PEX19—glaucoma	0.000306	0.00389	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.000303	0.00384	CbGpPWpGaD
Phenylbutazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000299	0.00379	CbGpPWpGaD
Phenylbutazone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000292	0.00371	CbGpPWpGaD
Phenylbutazone—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000292	0.00371	CbGpPWpGaD
Phenylbutazone—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000289	0.00368	CbGpPWpGaD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000283	0.00359	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	0.000275	0.0035	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000272	0.00345	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	0.000265	0.00337	CbGpPWpGaD
Phenylbutazone—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000262	0.00332	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—FGFR1OP—glaucoma	0.000259	0.00329	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HEYL—glaucoma	0.000259	0.00329	CbGpPWpGaD
Phenylbutazone—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.000255	0.00324	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000248	0.00315	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000238	0.00303	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	0.000236	0.003	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000219	0.00278	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000218	0.00277	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CA1—glaucoma	0.000217	0.00276	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000217	0.00275	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000211	0.00268	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CTSA—glaucoma	0.00021	0.00267	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000207	0.00263	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000199	0.00253	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CA2—glaucoma	0.000198	0.00252	CbGpPWpGaD
Phenylbutazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000197	0.0025	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—GSTT1—glaucoma	0.000195	0.00247	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000194	0.00246	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000194	0.00246	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—TNF—glaucoma	0.000192	0.00244	CbGpPWpGaD
Phenylbutazone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000189	0.00241	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000188	0.00239	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.000188	0.00238	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	0.000187	0.00238	CbGpPWpGaD
Phenylbutazone—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000187	0.00238	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.000175	0.00222	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000165	0.0021	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HDAC9—glaucoma	0.000162	0.00205	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—NGFR—glaucoma	0.00016	0.00204	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000159	0.00202	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—CYP1B1—glaucoma	0.000155	0.00197	CbGpPWpGaD
Phenylbutazone—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000155	0.00196	CbGpPWpGaD
Phenylbutazone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000154	0.00195	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000151	0.00192	CbGpPWpGaD
Phenylbutazone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.00015	0.00191	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	0.000149	0.00189	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000145	0.00184	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—TXN—glaucoma	0.00014	0.00178	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—BDNF—glaucoma	0.000139	0.00177	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000139	0.00177	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000138	0.00175	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CA5A—glaucoma	0.000137	0.00173	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NARFL—glaucoma	0.000137	0.00173	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL1A—glaucoma	0.000134	0.0017	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000128	0.00162	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000126	0.00161	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000126	0.0016	CbGpPWpGaD
Phenylbutazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000125	0.00159	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—GSTM1—glaucoma	0.000124	0.00158	CbGpPWpGaD
Phenylbutazone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000123	0.00157	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000121	0.00154	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	0.00012	0.00152	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000118	0.0015	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000115	0.00146	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GSTT1—glaucoma	0.000108	0.00138	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NARFL—glaucoma	0.000108	0.00138	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CA5A—glaucoma	0.000108	0.00138	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000108	0.00137	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	0.000105	0.00134	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000104	0.00132	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—GSTT1—glaucoma	0.000102	0.0013	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000101	0.00129	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000101	0.00128	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	0.000101	0.00128	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	9.88e-05	0.00126	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LRP12—glaucoma	9.81e-05	0.00125	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	9.55e-05	0.00121	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	9.49e-05	0.00121	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	9.33e-05	0.00119	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.74e-05	0.00111	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CDKN2B—glaucoma	8.69e-05	0.0011	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ABCA1—glaucoma	8.64e-05	0.0011	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CYP1B1—glaucoma	8.64e-05	0.0011	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—CYP1B1—glaucoma	8.16e-05	0.00104	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	8.12e-05	0.00103	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	8.07e-05	0.00103	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	8.05e-05	0.00102	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.62e-05	0.000968	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MTHFR—glaucoma	7.29e-05	0.000925	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CA5A—glaucoma	7.18e-05	0.000912	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NARFL—glaucoma	7.18e-05	0.000912	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	7.11e-05	0.000903	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	6.95e-05	0.000882	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GSTM1—glaucoma	6.9e-05	0.000877	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—APOE—glaucoma	6.78e-05	0.000862	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—GSTT1—glaucoma	6.75e-05	0.000858	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CAV1—glaucoma	6.72e-05	0.000854	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CA1—glaucoma	6.67e-05	0.000847	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MMP9—glaucoma	6.59e-05	0.000836	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—GSTM1—glaucoma	6.52e-05	0.000829	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CTSA—glaucoma	6.46e-05	0.00082	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	6.43e-05	0.000817	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	6.41e-05	0.000814	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGFR1OP—glaucoma	6.32e-05	0.000803	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HEYL—glaucoma	6.32e-05	0.000803	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—BAD—glaucoma	6.32e-05	0.000803	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—MTHFR—glaucoma	6.1e-05	0.000775	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CA2—glaucoma	6.1e-05	0.000775	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.96e-05	0.000757	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.96e-05	0.000757	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—APOE—glaucoma	5.68e-05	0.000721	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CAV1—glaucoma	5.63e-05	0.000715	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—CYP1B1—glaucoma	5.38e-05	0.000684	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	5.31e-05	0.000674	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CA1—glaucoma	5.29e-05	0.000672	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CTSA—glaucoma	5.13e-05	0.000651	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NOS3—glaucoma	5.08e-05	0.000645	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TNF—glaucoma	5.07e-05	0.000644	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CA2—glaucoma	4.84e-05	0.000615	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.84e-05	0.000614	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NARFL—glaucoma	4.73e-05	0.000601	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CA5A—glaucoma	4.73e-05	0.000601	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.73e-05	0.000601	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.73e-05	0.000601	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTGS2—glaucoma	4.65e-05	0.00059	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TP53—glaucoma	4.47e-05	0.000568	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CDKN1B—glaucoma	4.4e-05	0.000559	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.3e-05	0.000546	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—TXN—glaucoma	4.3e-05	0.000546	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—NOS3—glaucoma	4.26e-05	0.000541	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.24e-05	0.000539	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.02e-05	0.000511	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HDAC9—glaucoma	3.94e-05	0.000501	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.92e-05	0.000498	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—glaucoma	3.89e-05	0.000494	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.88e-05	0.000493	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CA1—glaucoma	3.51e-05	0.000445	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.45e-05	0.000438	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—TXN—glaucoma	3.41e-05	0.000433	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CTSA—glaucoma	3.39e-05	0.000431	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTT1—glaucoma	3.33e-05	0.000423	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CA2—glaucoma	3.21e-05	0.000407	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.13e-05	0.000398	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.13e-05	0.000398	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.11e-05	0.000395	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.08e-05	0.000392	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.04e-05	0.000386	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.69e-05	0.000341	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ABCA1—glaucoma	2.65e-05	0.000337	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP1B1—glaucoma	2.65e-05	0.000337	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTT1—glaucoma	2.64e-05	0.000336	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CA1—glaucoma	2.31e-05	0.000294	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—TXN—glaucoma	2.26e-05	0.000287	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CTSA—glaucoma	2.24e-05	0.000284	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTM1—glaucoma	2.12e-05	0.00027	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN2B—glaucoma	2.12e-05	0.000269	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CA2—glaucoma	2.11e-05	0.000269	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP1B1—glaucoma	2.11e-05	0.000268	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCA1—glaucoma	2.11e-05	0.000268	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.06e-05	0.000262	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.04e-05	0.000259	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—MTHFR—glaucoma	1.88e-05	0.000238	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTHFR—glaucoma	1.78e-05	0.000226	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTT1—glaucoma	1.75e-05	0.000222	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOE—glaucoma	1.75e-05	0.000222	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CAV1—glaucoma	1.73e-05	0.00022	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTM1—glaucoma	1.68e-05	0.000214	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOE—glaucoma	1.66e-05	0.00021	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CAV1—glaucoma	1.64e-05	0.000208	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BAD—glaucoma	1.54e-05	0.000196	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TXN—glaucoma	1.49e-05	0.000189	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MTHFR—glaucoma	1.49e-05	0.000189	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.41e-05	0.000179	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP1B1—glaucoma	1.4e-05	0.000177	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCA1—glaucoma	1.4e-05	0.000177	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOE—glaucoma	1.39e-05	0.000176	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CAV1—glaucoma	1.37e-05	0.000174	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NOS3—glaucoma	1.31e-05	0.000166	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS3—glaucoma	1.24e-05	0.000157	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—glaucoma	1.2e-05	0.000152	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTT1—glaucoma	1.16e-05	0.000147	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTM1—glaucoma	1.12e-05	0.000142	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN1B—glaucoma	1.07e-05	0.000136	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NOS3—glaucoma	1.04e-05	0.000132	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTHFR—glaucoma	9.86e-06	0.000125	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCA1—glaucoma	9.2e-06	0.000117	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP1B1—glaucoma	9.2e-06	0.000117	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOE—glaucoma	9.18e-06	0.000117	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CAV1—glaucoma	9.09e-06	0.000116	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTM1—glaucoma	7.36e-06	9.35e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NOS3—glaucoma	6.88e-06	8.73e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTHFR—glaucoma	6.5e-06	8.26e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—glaucoma	6.29e-06	7.99e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOE—glaucoma	6.05e-06	7.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CAV1—glaucoma	6e-06	7.62e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NOS3—glaucoma	4.54e-06	5.76e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—glaucoma	4.15e-06	5.27e-05	CbGpPWpGaD
